Cost-effectiveness of edoxaban versus rivaroxaban for stroke prevention in patients with nonvalvular atrial fibrillation (NVAF) in the US

• Main Authors: Miller JD (Author), Ye X (Author), Lenhart GM (Author), Farr AM (Author), Tran OV (Author), Kwong WJ (Author), Magnuson EA (Author), Weintraub WS (Author)
• Format: Book
• Published: Dove Medical Press, 2016-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Jeffrey D Miller,1 Xin Ye,2 Gregory M Lenhart,1 Amanda M Farr,1 Oth V Tran,1 W Jackie Kwong,2 Elizabeth A Magnuson,3 William S Weintraub41Truven Health Analytics Inc, Cambridge, MA, 2Daiichi Sankyo Inc, Parsippany, NJ, 3St Luke Mid-America Heart Institute, Kansas City, MO, 4Center for Heart and Vasc...